127 related articles for article (PubMed ID: 32308603)
21. Low bone density in breast cancer survivors in Korea: prevalence, risk factors and associations with health-related quality of life.
Kim SH; Cho YU; Kim SJ; Lee JE; Kim JH
Eur J Oncol Nurs; 2013 Apr; 17(2):196-203. PubMed ID: 22898655
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
23. Endocrine consequences of neuroblastoma treatment in children: 20 years' experience of a single center.
Geurten C; Geurten M; Hoyoux C; Lebrethon MC
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):347-354. PubMed ID: 30875326
[TBL] [Abstract][Full Text] [Related]
24. Cosmetic outcomes and complications reported by patients having undergone breast-conserving treatment.
Hill-Kayser CE; Vachani C; Hampshire MK; Di Lullo GA; Metz JM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):839-44. PubMed ID: 22137022
[TBL] [Abstract][Full Text] [Related]
25. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
26. Serum 25-hydroxy vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors.
Akinci MB; Sendur MA; Aksoy S; Yazici O; Ozdemir NY; Kos T; Yaman S; Altundag K; Zengin N
Asian Pac J Cancer Prev; 2014; 15(8):3377-81. PubMed ID: 24870725
[TBL] [Abstract][Full Text] [Related]
27. Quality of life in breast cancer patients--not enough attention for long-term survivors?
Holzner B; Kemmler G; Kopp M; Moschen R; Schweigkofler H; Dünser M; Margreiter R; Fleischhacker WW; Sperner-Unterweger B
Psychosomatics; 2001; 42(2):117-23. PubMed ID: 11239124
[TBL] [Abstract][Full Text] [Related]
28. Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors.
Santen RJ; Stuenkel CA; Davis SR; Pinkerton JV; Gompel A; Lumsden MA
J Clin Endocrinol Metab; 2017 Oct; 102(10):3647-3661. PubMed ID: 28934376
[TBL] [Abstract][Full Text] [Related]
29. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
[TBL] [Abstract][Full Text] [Related]
30. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
[TBL] [Abstract][Full Text] [Related]
31. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
Welnicka-Jaskiewicz M; Jassem J
Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354
[TBL] [Abstract][Full Text] [Related]
32. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
33. Relative mortality rates from incident chronic diseases among breast cancer survivors--a 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007.
Ording AG; Boffetta P; Garne JP; Nyström PM; Cronin-Fenton D; Frøslev T; Silliman R; Sørensen HT; Lash TL
Eur J Cancer; 2015 Apr; 51(6):767-75. PubMed ID: 25765753
[TBL] [Abstract][Full Text] [Related]
34. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics.
Brignardello E; Felicetti F; Castiglione A; Chiabotto P; Corrias A; Fagioli F; Ciccone G; Boccuzzi G
Eur J Endocrinol; 2013 Mar; 168(3):465-72. PubMed ID: 23258270
[TBL] [Abstract][Full Text] [Related]
35. GH-deficient survivors of childhood cancer: GH replacement during adult life.
Murray RD; Darzy KH; Gleeson HK; Shalet SM
J Clin Endocrinol Metab; 2002 Jan; 87(1):129-35. PubMed ID: 11788635
[TBL] [Abstract][Full Text] [Related]
36. Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.
Hurtado-de-Mendoza A; Jensen RE; Jennings Y; Sheppard VB
J Cancer Educ; 2018 Apr; 33(2):436-439. PubMed ID: 28205022
[TBL] [Abstract][Full Text] [Related]
37. Nutritional Status of Breast Cancer Survivors 1 Year after Diagnosis: A Preliminary Analysis from the Malaysian Breast Cancer Survivorship Cohort Study.
Majid HA; Keow LP; Islam T; Su TT; Cantwell M; Taib NA;
J Acad Nutr Diet; 2018 Apr; 118(4):705-713. PubMed ID: 28756991
[TBL] [Abstract][Full Text] [Related]
38. The management of menopausal symptoms in breast cancer survivors: case-based approach.
Lammerink EA; de Bock GH; Schröder CP; Mourits MJ
Maturitas; 2012 Nov; 73(3):265-8. PubMed ID: 22883373
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
40. Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA.
Spano JP; Beuzeboc P; Coeffic D; Arnould L; Lortholary A; Andre F; Ferrero JM
Breast; 2015 Aug; 24(4):376-83. PubMed ID: 25913287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
